SLC5A2 and Tinnitus: Given the proposed mechanisms of SGLT2 inhibitors beyond glycemic control—such as blood pressure reduction, anti-inflammatory and antifibrotic effects, the improvement of endothelial function, and reductions in vascular tone [15]—it is conceivable that microvascular alterations associated with sensorineural hearing loss and tinnitus may be positively influenced by these agents.